The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment.

Karin PurshouseJohn P ThomsonMahéva ValletLorna AlexanderIsaac BonisteelMaree BrennanDavid A CameronJonine D FigueroaElizabeth FurriePamela HaigMattea HeckHugh McCaughanPaul MitchellHeather McVicarsLorraine PrimroseInes SilvaKate TempletonNatalie WilsonPeter S Hall

Published in: The oncologist (2023)

This is the largest on-going longitudinal real-world dataset of patients undergoing ACT during the early stages of the COVID-19 pandemic. This preliminary analysis demonstrates that patients with solid tumors undergoing ACT have high protection from SARS-CoV-2 infection following COVID-19 vaccination. The SCCAMP study will evaluate long-term COVID-19 antibody trends, focusing on specific ACTs and patient subgroups.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
immune response
patients undergoing
squamous cell carcinoma
young adults
inflammatory response